hello can you help me with this question? cant seem to come close to an option. thanks!

Consolidated Statements of Operations (millions, except per share data) Sales Other revenue Total revenue Cost of sales Selling, general and administrative expenses Depreciation and amortization (exclusive of depreciation included in cost of sales) Operating income (EBIT) Net interest expense Net other (income) / expense Earnings from continuing operations before income taxes Provision for income taxes Net earnings from continuing operations Discontinued operations, net of tax Net earnings \begin{tabular}{|r|r|} \hline & I \\ \hline & 2021 \\ & 104,611 \\ & 1,394 \\ \hline & 106,005 \\ & 74,963 \\ & 19,752 \\ & 2,344 \\ \hline & 8,946 \\ \hline & 421 \\ \hline & -382 \\ \hline & 8,907 \\ \hline & 1,961 \\ \hline & 6,946 \\ \hline & 6,946 \\ \hline- & \\ \hline$ & \\ \hline \end{tabular} Basic eamings per share Continuing operations Discontinued operations Net earnings per share Diluted earnings per share Continuing operations Discontinued operations Net earnings per share Weighted average common shares outstanding Basic Diluted \begin{tabular}{cc} $ & 14.23 \\ \hline & \\ \hline$ & 14.23 \\ \hline$ & 14.10 \\ \hline$ & \\ \hline \end{tabular} 8.72 2020 $ 92,400 1,161 93,56 66,177 18,615 6,5392,230 2,2306,539977 165,546 \begin{tabular}{l} 1,178 \\ 4,368 \\ \hline \end{tabular} \begin{tabular}{ll} & 1,178 \\ \hline & 4,368 \\ \hline- & \\ \hline$ & 4,368 \\ \hline \end{tabular} $ 8.72 $ $ 8.64 \begin{tabular}{ll} & \\ \hline S & 8.64 \\ \hline \end{tabular} 488.10 500.60 505.40 492.70 505.40 Consolidated Statements of Cash Flows (millions) 2021 202 Operating activities Net earnings Earnings from discontinued operations, net of tax Net earnings from continuing operations $,946 - 6,946 4,368 Adjustments to reconcile net earnings to cash provided by c Depreciation and amortization Share-based compensation expense Deferred income taxes Gain on Dermstore sale Loss on debt extinguishment Noncash losses / (gains) and other, net Changes in operating accounts: Inventory Other assets Accounts payable Accrued and other liabilities Cash provided by operating activities-continuing operatio Cash provided by operating activities-discontinued opera Cash provided by operating activities Investing activities Expenditures for property and equipment Proceeds from disposal of property and equipment Proceeds from Dermstore sale Other investments Cash required for investing activities Financing activities 2,642 2,485 4,368 200 (184) (335) 512 67 86 Additions to long-term debt Reductions of long-term debt Dividends paid Repurchase of stock Stock option exercises (3,249) (1,661) (78) (137) 2,628 2,925 8,625(746) 1,931 1,93110,525 8,625 10,525 Cash required for financing activities Net (decrease) / increase in cash and cash equivalents (3,544) (2,649) 27 42 356 (3,154) 16 (2.591) 1,972 2,480 (1,147) (2,415) (1,548) (1,343) (7,356) (745) 8 (8,071) 23 (2,600) (2,000) 5,934 arget's annual declared dividend in its 2021 fiscal year (FY) was $3.38 per share. Using Target's FY 2021 diluted earnings per share (EPS) of $14.10 per share, what was Target's dividend payout ratio in FY 2021? A. Insufficient information is provided in the financial statements to calculate this answer. B. 70.2% C. 417.2% D. 24.0% E. 42.0% Consolidated Statements of Financial Position